CytoDyn Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
CytoDyn Inc. (CYDY) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of -$466.41 thousand for the 6-month period ending 2018-11-30, per its 10-Q filed 2019-01-09.
Discontinued › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2021-01-08
- CytoDyn Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2018-11-30 was $281.06K, a 66.12% decline year-over-year.
- CytoDyn Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2018-08-31 was -$747.47K.
- CytoDyn Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2018-05-31 was $4.13M, a 326.68% increase year-over-year.
- CytoDyn Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2018-02-28 was -$741.07K.
- CytoDyn Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2017 was $2.16M, a 234.81% increase from fiscal 2016.
- CytoDyn Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2016 was $646.50K, a 22.91% decline from fiscal 2015.
- CytoDyn Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2015 was $838.64K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month as first filed |
|---|---|---|---|---|---|
| 2018-11-30 | $281.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-09 | -$466.41K 10-Q · filed 2019-01-09 | $3.66M derived: sum of 3 quarters · filed 2021-01-08 | $2.92M derived: sum of 4 quarters · filed 2021-01-08 | |
| 2018-08-31 | -$747.47K 10-Q · filed 2018-10-09 | $3.38M derived: sum of 2 quarters · filed 2021-01-08 | $2.64M derived: sum of 3 quarters · filed 2021-01-08 | $3.47M derived: sum of 4 quarters · filed 2021-01-08 | |
| 2018-05-31 | $4.13M derived: 10-Q 12 month − 10-Q 9 month · filed 2021-01-08 | $3.39M derived: sum of 2 quarters · filed 2021-01-08 | $4.22M derived: sum of 3 quarters · filed 2021-01-08 | $3.85M 10-Q · filed 2021-01-08 | $1.69M 10-K · filed 2018-07-27 |
| 2018-02-28 | -$741.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-09 | $88.53K derived: sum of 2 quarters · filed 2018-04-09 | -$274.13K 10-Q · filed 2018-04-09 | $693.60K derived: sum of 4 quarters · filed 2018-07-27 | |
| 2017-11-30 | $829.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-08 | $466.93K 10-Q · filed 2018-01-08 | $1.43M derived: sum of 3 quarters · filed 2018-07-27 | $1.41M derived: sum of 4 quarters · filed 2018-07-27 | |
| 2017-08-31 | -$362.67K 10-Q · filed 2017-10-10 | $605.07K derived: sum of 2 quarters · filed 2018-07-27 | $578.40K derived: sum of 3 quarters · filed 2018-07-27 | ||
| 2017-05-31 | $967.73K derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-27 | $941.07K derived: sum of 2 quarters · filed 2018-07-27 | $2.16M 10-K · filed 2018-07-27 | ||
| 2017-02-28 | -$26.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-13 | $1.20M 10-Q · filed 2017-04-13 | |||
| 2016-11-30 | $1.22M 10-Q · filed 2017-01-13 | ||||
| 2016-05-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-20 | $1.29M derived: sum of 2 quarters · filed 2017-07-20 | $1.29M derived: sum of 3 quarters · filed 2017-07-20 | $646.50K 10-K · filed 2017-07-20 | -$646.50K 10-K · filed 2016-07-19 |
| 2016-02-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-04-13 | $0.00 derived: sum of 2 quarters · filed 2016-04-13 | -$646.50K 10-Q · filed 2016-04-13 | $648.11K derived: sum of 4 quarters · filed 2016-07-19 | |
| 2015-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-11 | -$646.50K 10-Q · filed 2016-01-11 | $648.11K derived: sum of 3 quarters · filed 2016-07-19 | -$613.44K derived: sum of 4 quarters · filed 2016-07-19 | |
| 2015-08-31 | -$646.50K 10-Q · filed 2015-10-09 | $648.11K derived: sum of 2 quarters · filed 2016-07-19 | -$613.44K derived: sum of 3 quarters · filed 2016-07-19 | ||
| 2015-05-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-19 | $33.07K derived: sum of 2 quarters · filed 2016-07-19 | $838.64K 10-K · filed 2016-07-19 | ||
| 2015-02-28 | -$1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-10 | -$455.97K 10-Q · filed 2015-04-10 | |||
| 2014-11-30 | $805.58K 10-Q · filed 2015-01-12 |